United Pharm (033270) — Strategic Asset Allocation Index
United Pharm (033270) has a Strategic Asset Allocation Index of 50.4% as of September 2015. Strategic assets (PP&E of ₩74.12 Billion plus long-term investments of ₩11.90 Billion) total ₩86.02 Billion, measured against net assets of ₩170.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 033270 equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
United Pharm Strategic Asset Allocation Index (2011–2014)
This chart shows how United Pharm's Strategic Asset Allocation Index has evolved across 4 annual periods from 2011 to 2014. As of September 2015, the index stands at 50.4%, representing strategic assets of ₩86.02 Billion against net assets of ₩170.68 Billion KRW. For live market cap and overall valuation, see United Pharm (033270) total market value.
Annual Strategic Asset Allocation Index for United Pharm (2011–2014)
The table below presents the year-by-year Strategic Asset Allocation Index for United Pharm from 2011 to 2014, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See United Pharm shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2014 | 48.9% | ₩79.07 Billion | ₩67.00 Billion | ₩12.07 Billion | ₩161.83 Billion | ▼ -3.6 pp |
| 2013 | 52.5% | ₩74.20 Billion | ₩65.49 Billion | ₩8.71 Billion | ₩141.44 Billion | ▲ +1.4 pp |
| 2012 | 51.0% | ₩68.12 Billion | ₩59.69 Billion | ₩8.43 Billion | ₩133.48 Billion | ▼ -3.9 pp |
| 2011 | 55.0% | ₩62.14 Billion | ₩53.65 Billion | ₩8.49 Billion | ₩113.04 Billion | — |